Infectious Agents and Cancer

短名Infect Agents Cancer
Journal Impact3.26
国际分区ONCOLOGY(Q2)
期刊索引SCI Q2中科院 2 区
ISSN1750-9378
h-index47
国内分区医学(2区)医学免疫学(3区)医学肿瘤学(3区)

INFECTIOUS AGENTS AND CANCER 是一本开放获取、同行评议的在线期刊,涵盖基础、临床、流行病学和转化研究的各个方面,深入了解慢性感染与癌症之间的关系。该期刊欢迎在病原体相关癌症领域投稿和其他相关主题,特别是:• HPV 和肛门生殖器癌,以及头颈癌;• EBV 和伯基特淋巴瘤;• HCV/HBV 和肝细胞癌以及淋巴组织增生性疾病;• HHV8 和卡波西肉瘤;• HTLV 和白血病;• 低收入和中等收入国家的癌症。在过去 50 年中,感染与癌症之间的联系已经确立,在发达国家,感染相关癌症占癌症的 16%,在欠发达国家占 33%仅针对两种致癌病毒开发了预防性疫苗,这凸显了通过疫苗接种预防与感染相关的癌症的机会发现在为其他致癌剂开发疫苗之前仍然存在的差距。这些差距是由于对许多导致癌症的病原体的基本生物学、自然史、流行病学、它们用于导致癌症的机制以及如何中断人类癌症进展的不完全了解所致。早期诊断或识别具有高进展风险的病变代表了该领域当前最关键的研究领域,得到了基因组学和蛋白质组学技术的最新进展的支持。

期刊主页投稿网址
涉及主题医学生物遗传学内科学病理免疫学癌症病毒学化学生物化学基因家庭医学病毒宫颈癌数学外科人类免疫缺陷病毒(HIV)肿瘤科社会学癌症研究人口学
出版信息出版商: BioMed Central Ltd出版周期: 期刊类型: journal
基本数据创刊年份: 2006原创研究文献占比74.58%自引率:3.20%Gold OA占比: 100.00%
平均审稿周期 网友分享经验:17 Weeks

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

Human papillomavirus type-specific distribution in cervical intraepithelial neoplasia and cancer in The Gambia prior to HPV immunization programme: a baseline for monitoring the quadrivalent vaccine

2024-9-12

Ranking the attribution of high-risk genotypes among women with cervical precancers and cancers: a cross-sectional study in Ningbo, China

2024-9-12

High-grade B-cell lymphoma with 11q aberration in the HIV setting: a clinicopathological study of 10 cases and literature review

2024-9-11

Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic

2024-8-29

From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis

2024-8-27

The viral origins of breast cancer

2024-8-26

Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation

2024-8-12

Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis

2024-8-10

HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3

2024-8-8

High-risk human papillomavirus genotyping in cervical cancers in Tanzania

2024-8-5

CTSG may inhibit disease progression in HIV-related lung cancer patients by affecting immunosuppression

2024-7-30

Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma

2024-7-27

Genetic variants of LncRNAs HOTTIP and MEG3 influence nasopharyngeal carcinoma susceptibility and clinicopathologic characteristics in the Southern Chinese population

2024-7-24

Understanding lactate in the development of Hepatitis B virus-related hepatocellular carcinoma

2024-7-15

Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis

2024-7-2

A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma

2024-6-28

Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study

2024-6-19

Vaginal microbiota and gynecological cancers: a complex and evolving relationship

2024-6-14

Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors

2024-6-10

The patients with multiple myeloma were infected with COVID-19 during autologous stem cell transplantation: case report and literature review

2024-5-27

Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi

2024-5-17

Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation

2024-5-11

The performance of single and combination test strategies using visual inspection, cytology, high-risk HPV DNA and HPV16/18 to screen South African women with and without HIV-infection

2024-5-9

Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study

2024-5-1

Expression of 10 circulating cytokines/chemokines in HBV-related liver disease

2024-5-1

Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy

2024-4-30

Researchers should no longer delay implementation of Pap screening in low and middle income countries pending research into novel screening approaches

2024-4-26

Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial

2024-4-25

Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis

2024-4-25

Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma

2024-4-23

Undifferentiated carcinoma of the liver with osteoclast-like giant cells: a case report and literature review

2024-4-20

Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer

2024-4-19

Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China

2024-4-15

Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?

2024-4-4

A prognostic model for Schistosoma japonicum infection-associated liver hepatocellular carcinoma: strengthening the connection through initial biological experiments

2024-3-21

No detectable truncating mutations in large T antigen (LT-Ag) sequence of Merkel cell polyomavirus (MCPyV) DNA obtained from porocarcinomas

2024-3-21

Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection

2024-3-14

Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly

2024-3-4

Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa

2024-3-2

The global burden of cervical cancer requiring surgery: database estimates

2024-2-26

Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States

2024-2-20

The causality between CD8+NKT cells and CD16−CD56 on NK cells with hepatocellular carcinoma: a Mendelian randomization study

2024-1-20

A systematic review of endometrial cancer clinical research in Africa

2024-1-12

The prognostic role of PD-L1 expression and the presence of polyomavirus in Merkel cell carcinoma cases

2024-1-4

Willingness to accept human papilloma virus vaccination and its associated factors among parents with eligible daughters in Addis Zemen town, Northwest Ethiopia

2023-12-21

Correction: Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?

2023-12-11

Polygenic risk scores for cervical HPV infection, neoplasia and cancer show potential for personalised screening: comparison of two methods

2023-12-7

Post-conization surveillance in an organized cervical screening program with more than 23,000 years of follow-up

2023-12-6

Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology

2023-12-6

Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 study)

2023-12-5

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司